Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 6,000 shares at $17.14 ($103K) on 2020-11-02, disclosed to the SEC on 2020-11-04.
Open-market sale of $103k KALV by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |